IFIH1 and interstitial lung disease: In this prospective study, we systematically described the clinical and immune characteristics of patients with IIM-ILD, with a focus on lung involvement, and separately discussed the two subpopulations, anti-MDA5+ DM and ASS, which are most susceptible to ILD; the relationships among peripheral blood lymphocyte characteristics, clinical parameters, and disease progression were also discussed.